| Literature DB >> 11354371 |
A J Cocuzza1, D R Chidester, B C Cordova, S Jeffrey, R L Parsons, L T Bacheler, S Erickson-Viitanen, G L Trainor, S S Ko.
Abstract
Two series of efavirenz analogues have been developed: one in which the cyclopropane ring has been replaced by small heterocycles and another in which the entire acetylenic side chain has been replaced by alkyloxy groups. Several members of both series show equivalent potency to efavirenz against both wild-type virus and the key K103N mutant.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11354371 DOI: 10.1016/s0960-894x(01)00192-5
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823